Navigation Links
Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2019
Date:5/15/2012

Preclinical Pipeline 545.4 Neuroendocrine Carcinoma Therapeutics- Clinical Pipeline by Mechanism of Action 555.5 Technology Trends Analytic Framework 555.6 Neuroendocrine Carcinoma Therapeutics - Key Late Stage Pipeline Drugs in Clinical Development 585.7 Molecule Profile for Key Late Stage Pipeline Drugs under Clinical Development 585.7.1 Avastin (bevacizumab) 585.7.2 Lutathera ([177Lutetium]-DOTA0-Tyr3-Octreotate) 595.7.3 Paseriotide (SOM 230) 605.7.4 Somatuline Autogel (lanreotide acetate) 615.8 Key Takeaway 616 Neuroendocrine Carcinoma Therapeutics - Clinical Trials Mapping 626.1 Clinical Trials by Region/Country (The US, EU5 and Japan) 626.2 Clinical Trials by Phase 636.3 Clinical Trials by Trial Status 646.4 Prominent Sponsors 656.5 Top Companies Participating in Neuroendocrine Carcinoma Therapeutics Clinical Trials 677 Neuroendocrine Carcinoma Therapeutics- Strategic Assessment 687.1 Future Market Competition Scenario 688 Neuroendocrine Carcinoma Therapeutics - Future Players 708.1 Introduction 708.2 Company Profiles for the Promising Drugs 708.2.1 Advanced Accelerator Applications S.A 708.2.2 Novartis AG 718.2.3 F. Hoffmann-La Roche 738.2.4 Ipsen SA 748.3 Other Companies in the Neuroendocrine Carcinoma Therapeutics Market 769 Neuroendocrine Carcinoma Therapeutics- Licensing and Partnership Deals 7710 Neuroendocrine Carcinoma Therapeutics - Appendix 7910.1 Market Definitions 7910.2 Abbreviations 7910.3 Methodology 8010.3.1 Coverage 8110.3.2 Secondary Research 8110.3.3 Forecasting 8110.3.4 Primary Research 8310.3.5 Expert Panel Validation 8410.4 Contact Us 8410.5 Disclaimer 8410.6 Bibliography 84

List of Tables

Table 1: GEP-NETs WHO Classification 7Table 2:GEP-NETs Classification 8Table 3: Historical Prevalence for Neuroendocrine Carcinoma* for Seven Major Markets 9Table 4: Forecast Prevalence for Neuroendocrine Carcinoma* for Seven Major Markets 10Table 5: Symptoms of Pancreatic NETs/Islet Cell Tumors 12Table 6:Diagnosis Techniques by S
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Positive Phase 2 Trial Results from Neuroendocrine Tumor Cohort Presented at CIRSE
2. Cylene Pharmaceuticals Initiates Phase II Clinical Trial of Quarfloxin (CX-3543) in Patients With Carcinoid/Neuroendocrine Tumors
3. Childhood Obesity Linked to Increased Risk of Hepatocellular Carcinoma in Adulthood
4. Argos Therapeutic Arcelis™ Immunotherapy AGS-003 in Combination With Sunitinib Shows Statistically Significant Correlation of Immune System Response to Overall Survival in Phase 2 Study in Patients with Advanced Renal Cell Carcinoma (RCC)
5. SFJ Pharma Ltd. II, Announces Agreement With Pfizer to Develop Axitinib for Adjuvant Treatment of Renal Cell Carcinoma
6. Targeted Gold Nanoparticles and Noninvasive Radio Fields Attacking One of the Deadliest and Least Curable Types of Cancer: Pancreatic Carcinoma
7. Aegera Therapeutics Reports Survival Data from the Phase 1 Portion of its Phase 1-2 Study of AEG35156 in Combination with Sorafenib in Patients with Advanced Hepatocellular Carcinoma
8. Aegera Therapeutics Initiates a Randomized Phase 2 Study with AEG35156 for the Treatment of Hepatocellular Carcinoma
9. Aratana Therapeutics Appoints Craig Tooman to Board of Directors
10. Immunomic Therapeutics Receives IND Authorization for Phase I Study of JRC-LAMP-Vax Vaccine to Treat Japanese Red Cedar (Sugi) Allergy
11. Silence Therapeutics Partner, Quark Pharmaceuticals, Extends its Agreement With Pfizer to Develop one of Its Compounds Containing Silences AtuRNAi in a New Indication
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... A Finnish-Swedish research group at the Institute for ... Karolinska institutet, Stockholm, has developed a novel "man ... infection. This innovative diagnostic aid was described in ... August. The method is based on computer vision ... systems combined with visualization of only the diagnostically ...
(Date:8/21/2014)... Texas (PRWEB) August 21, 2014 ... Seaweed Fertilizer Industry” is a professional and ... market. The report provides basic Seaweed Fertilizer ... and industry chain structure as well as ... market analysis, including domestic market as well ...
(Date:8/21/2014)... His Majesty Willem-Alexander, King of the Netherlands ... His Majesty Willem-Alexander, King of the Netherlands, has announced ... POET-DSM Advanced Biofuels’ Project LIBERTY cellulosic ethanol plant in ... will take part in the Grand Opening Ceremony to ... p.m. and tour the plant. POET-DSM is a joint ...
(Date:8/21/2014)... The College of New Rochelle announced today ... Mid-Hudson Region to be designated as a START-UP NY ... qualified “high-technology” businesses that align with the College’s academic ... been selected for the START-UP NY program and extremely ... economic development in New York by growing business and ...
Breaking Biology Technology:A novel 'man and machine' decision support system makes malaria diagnostics more effective 2Internationals Seaweed Fertilizer Industry 2014 Development Trend Analysis in New Research Study at DeepResearchReports.com 2Internationals Seaweed Fertilizer Industry 2014 Development Trend Analysis in New Research Study at DeepResearchReports.com 3His Majesty Willem-Alexander, King of the Netherlands, to Attend Project LIBERTY opening 2His Majesty Willem-Alexander, King of the Netherlands, to Attend Project LIBERTY opening 3The College of New Rochelle Becomes First Private College in Mid-Hudson Region to Earn START-UP NY Designation 2The College of New Rochelle Becomes First Private College in Mid-Hudson Region to Earn START-UP NY Designation 3
... Participant Eyes with Wet AMD ... to Electronic Case Report Forms (eCRFs), ... clinical data solutions on demand company, today expanded its,international ... device company specializing in the early detection of,AMD, has ...
... Dec. 13 Anesiva,Inc. (Nasdaq: ANSV ) ... offering,of 11,111,111 shares of its common stock at ... closing bid price on December 12, 2007, for,approximately ... and commissions (approximately $50 million if the underwriters,over-allotment ...
... existing current 2008 convertible notes, and extended the maturity to 2011 on ... ... Dec. 13 Cell Therapeutics, Inc.,("CTI" or the "Company") (Nasdaq and MTAX: ... Convertible Senior,Notes (the "New Notes") due 2011 and 5,459,574 shares of its ...
Cached Biology Technology:Notal Vision chooses TrialStat's ClinicalAnalytics 4.0 for age-related macular degeneration (AMD) device trial 2Notal Vision chooses TrialStat's ClinicalAnalytics 4.0 for age-related macular degeneration (AMD) device trial 3Anesiva Raises $45 Million in Common Stock Offering 2Cell Therapeutics, Inc. Announces Issuance of $23.25 Million in New Convertible Senior Notes in Exchange for $36.08 Million of Existing Convertible Senior Subordinated and Subordinated Notes 2Cell Therapeutics, Inc. Announces Issuance of $23.25 Million in New Convertible Senior Notes in Exchange for $36.08 Million of Existing Convertible Senior Subordinated and Subordinated Notes 3
(Date:8/21/2014)... University (ANU) team has successfully replicated one of the ... systems powered by sunlight which could manufacture hydrogen as ... sunlight. It is an exciting prospect to use them ... said Dr Kastoori Hingorani, from the ARC Centre of ... of Biology. , Hydrogen offers potential as a zero-carbon ...
(Date:8/20/2014)... George E. Fox, a John and Rebecca Moores Professor ... was named a fellow in the International Society for the ... is one of four members two from the U.S., ... fellows in 2014. Fellows are elected every three years, and ... members from more than 20 countries, the ISSOL includes researchers ...
(Date:8/20/2014)... research finds life can persist in a cold, dark ... a team that examined waters and sediments from a ... found the extreme environment supports microbial ecosystems. , ... her colleagues has implications for life in other extreme ... The findings are published in the current edition of ...
Breaking Biology News(10 mins):Water and sunlight the formula for sustainable fuel 2UH professor named fellow by International Astrobiology Society 2University of Tennessee research uncovers subglacial life beneath Antarctic ice sheet 2
... study by researchers at the Salk Institute for Biological ... its name as "guardian of the genome", not only ... but also controls somatic cell reprogramming. Although scientists ... as skin cells into so-called induced pluripotent stem cells ...
... A chemical found in blueberry leaves has shown a strong ... opening up a new avenue for treating chronic HCV infections, ... to cirrhosis and liver cancer. Among the areas ... of southern Japan, a trend that led Hiroaki Kataoka and ...
... numbers of novel marine microbes could lead to more ... conditions such as epilepsy, diabetes, flu and other viruses, ... such as agrochemicals. Researchers at Heriot-Watt University and ... company Ingenza Ltd are searching for new enzymes for ...
Cached Biology News:Tumor suppressor pulls double shift as reprogramming watchdog 2Tumor suppressor pulls double shift as reprogramming watchdog 3Marine microbes creating green waves in industry 2Marine microbes creating green waves in industry 3
...
... The Fujifilm Life Science FLA-5100 imaging ... samples as large as 40 x 46cm ... 10 microns. This system is especially suitable ... and general array analysis for genomics., Fuji ...
Physical Form: saline suspension with ethanol Particle Dim: mean particle size 50 μm Matrix: HyperD F. Useful for the removal of detergents from protein samples....
General description: MaxiSorp TM surface is ideal for arraying molecules with mixed hydrophilic/hydrophobic domains such as proteins ID clarifier: Maxisorp(tm) with lid...
Biology Products: